Company profile
Avalo Therapeutics
Advancing an inspired pipeline of novel IL-1β therapies focused on treating unmet medical needs.
- Industry
- Biotechnology
- Employees
- 48
- Headquarters
- Chesterbrook, Pennsylvania
- Founded
- 2011
- LinkedIn followers
- 6,905
- Office locations
- 1
Avalo Therapeutics company summary
Avalo Therapeutics is a company in the Biotechnology industry, headquartered in Chesterbrook, Pennsylvania, founded in 2011. On LinkedIn the company has around 48 employees and 6,905 followers. Its listed specialties include immunology, IL-1β, inflammation, dermatology, rheumatology.
What technology does Avalo Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Avalo's lead asset, abdakibart, is an anti-IL-1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX-010, a long-acting next-generation anti-IL-1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.
Specialties
Where is Avalo Therapeutics located?
Avalo Therapeutics lists 1 location.
Compare companies similar to Avalo Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Avalo Therapeutics avalotx.com | Biotechnology | 48 | 2011 | Chesterbrook, Pennsylvania |
Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Avalo Therapeutics
What does Avalo Therapeutics do?
Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Avalo's lead asset, abdakibart, is an anti-IL-1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX-010, a long-acting next-generation anti-IL-1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.
How many employees does Avalo Therapeutics have?
Avalo Therapeutics has around 48 employees on LinkedIn.
Where is Avalo Therapeutics headquartered?
Avalo Therapeutics is headquartered in Chesterbrook, Pennsylvania.
When was Avalo Therapeutics founded?
Avalo Therapeutics was founded in 2011.
Build a lead list from companies like Avalo Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.